- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04679220
36-Months Clinical Evaluation of Preheated and Room Temperature Resin Composite
December 17, 2020 updated by: Mansoura University
36-Months Clinical Evaluation of Preheated Resin Composite
Summary The aim of this study was to evaluate the effect of preheating resin composite (RC) on clinical performance of class I restorations in a period of 3-years using a split-mouth double-blinded randomized design.
Study Overview
Detailed Description
The description of the experimental design followed the Consolidated Standards of Reporting Trials (CONSORT) statement.
The present study was a double-blinded (patients and examiner) randomized clinical trial anticipating the split mouth design.
Thirty-five adult patients seeking dental treatment in Operative Department clinic at Faculty of Dentistry, University of Mansoura were enrolled in the current study with a total of 70 Class I restorations.
No advertisement was made for participant recruitment, forming a sample of convenience.
Each patient much sign a consent form before participating in the current study.
The study was conducted from October 2017 to June 2020 as a part of Doctoral dissertation.
Mansoura University institution's ethics committee approved the form and protocol before conducting the study.
The sample size was calculated based on the clinical success rate (100% retention rate at 3 years) of posterior class I restorations restored with nanofilled composite observed in a previous study.28
According to several parameters including a significance level of 5%, the power of the test was calculated to be 80%, and equivalent limit of 15%.
Upon these data, a sample size of 30 subjects was appropriate.
Allowing for a 20% drop-out, sample size was set totalizing 35 subjects.
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Dakahlia
-
Mansoura, Dakahlia, Egypt, 35516
- Faculty of Dentistry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 30 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with primary caries involving occlusal surface only with ICDAS 2 and 3
- Patients with cavities no more than one-third of the intercuspal distance
- Patients must have a good oral hygiene;
- Patients with tooth gives positive response to testing with an electric pulp tester
- Patients with normal and full occlusion,
- Patients with opposing teeth should be natural with no restorations.
Exclusion Criteria:
- High caries risk patients with extremely poor oral hygiene,
- Patients involved in orthodontic treatment or periodontal surgery,
- Patients with periodontally involved teeth (chronic periodontitis)
- Patients with abutments should be excluded.
- Patients with heavy bruxism habits and clenching
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Non-heated Resin Composite group
Patients received Non-heated nanofilled resin composite on one side of the mouth
|
For preheating RC prior to placement, a device called Therma-flo TM RC warming kit (Vista, Wisconsin, USA) was used according to manufacturer's instructions to preheat resin composites
|
Placebo Comparator: Preheated Resin Composite group
Patients received preheated nanofilled resin composite on the other side of the mouth
|
For preheating RC prior to placement, a device called Therma-flo TM RC warming kit (Vista, Wisconsin, USA) was used according to manufacturer's instructions to preheat resin composites
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage % of patients with marginal staining
Time Frame: 3 years after restoration procedure
|
Percentage of marginal staining in patients was clinically assessed using World Dental Federation FDI parameters using a scale from 1 to 5 scores (clinically very good, clinically good, clinically satisfactory, clinically unsatisfactory and clinically poor)
|
3 years after restoration procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2017
Primary Completion (Actual)
June 1, 2020
Study Completion (Actual)
June 30, 2020
Study Registration Dates
First Submitted
December 14, 2020
First Submitted That Met QC Criteria
December 17, 2020
First Posted (Actual)
December 22, 2020
Study Record Updates
Last Update Posted (Actual)
December 22, 2020
Last Update Submitted That Met QC Criteria
December 17, 2020
Last Verified
December 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 36.MCEPRCRCL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
Study Protocol, Statistical Analysis Plan can be shared to other researchers
IPD Sharing Time Frame
Data will be available within 3 Months for 3 years
IPD Sharing Access Criteria
for anyone
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Leakage
-
Cairo UniversityRecruiting
-
Mansoura UniversityCompleted
-
Mansoura UniversityCompleted
-
University of JordanCompletedDental Caries | Pulp Disease, Dental | Dental LeakageJordan
-
Zafer Cavit Cehreli, DDS, PhDUnknownDental Caries in Children | Dental Caries on Pit and Fissure Surface | Dental LeakageUnited States
-
Prince Sattam Bin Abdulaziz UniversityCompletedDental LeakageSaudi Arabia
-
Karolinska University HospitalJansson, Anders, M.D.Completed
-
University of OklahomaRecruitingAir LeakageUnited States
-
NorthShore University HealthSystemTerminatedStoma Site LeakageUnited States
-
Coloplast A/SCompletedClinical Investigation of an Improved Two-piece Stoma Product for People Living With a Stoma (CP343)Stoma Site LeakageUnited States
Clinical Trials on Preheating
-
Northern Orthopaedic Division, DenmarkCompleted
-
Alshimaa Nasser MahmoudCompletedPreheating of Resin CompositeEgypt